Dupont Capital Management’s NewAmsterdam Pharma NAMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18 | Hold |
1
| – | – | ﹤0.01% | 102 |
|
|
2025
Q1 | $20 | Hold |
1
| – | – | ﹤0.01% | 103 |
|
|
2024
Q4 | $26 | Hold |
1
| – | – | ﹤0.01% | 104 |
|
|
2024
Q3 | $17 | Hold |
1
| – | – | ﹤0.01% | 121 |
|
|
2024
Q2 | $19 | Hold |
1
| – | – | ﹤0.01% | 131 |
|
|
2024
Q1 | $24 | Hold |
1
| – | – | ﹤0.01% | 145 |
|
|
2023
Q4 | $11 | Hold |
1
| – | – | ﹤0.01% | 152 |
|
|
2023
Q3 | $9 | Hold |
1
| – | – | ﹤0.01% | 221 |
|
|
2023
Q2 | $12 | Hold |
1
| – | – | ﹤0.01% | 621 |
|
|
2023
Q1 | $13 | Hold |
1
| – | – | ﹤0.01% | 738 |
|
|
2022
Q4 | $11 | Buy |
+1
| New | +$11 | ﹤0.01% | 1409 |
|